BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Ohr Pharmaceutical 

1245 Brickyard Road
Suite 590
Salt Lake City  Utah  84106  U.S.A.
Phone: 347-753-4389 Fax: n/a


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Ohr Pharmaceutical (OHRP) To Announce Fiscal 2014 Financial Results And Host Conference Call On Monday, December 22 12/19/2014 7:52:33 AM
Ohr Pharmaceutical (OHRP) To Present At The Oppenheimer 25th Annual Healthcare Conference 12/3/2014 4:04:35 PM
Ohr Pharmaceutical (OHRP) To Host Key Opinion Leader Meeting And Webcast On October 31 In New York City 10/27/2014 10:32:59 AM
Ohr Pharmaceutical (OHRP) Announces New Positive Anatomic And Visual Acuity Data On OHR-102 (Squalamine Eye Drops) IMPACT Study Presented At The 2014 American Academy of Ophthalmology Scientific Meeting 10/20/2014 6:29:18 AM
Ohr Pharmaceutical (OHRP) Announces Successful End Of Phase 2 Meeting With The FDA On Squalamine Eye Drops (OHR-102) In Wet AMD 10/14/2014 7:40:24 AM
Ohr Pharmaceutical (OHRP) Announces Squalamine Eye Drop (OHR-102) Clinical Data Presentations At The 2014 American Academy of Ophthalmology Scientific Meeting 10/7/2014 7:46:37 AM
Ohr Pharmaceutical (OHRP) Announces Squalamine Eye Drop (OHR-102) Clinical Data Presentations At The Retina Society 47th Annual Scientific Meeting 9/9/2014 9:02:15 AM
Ohr Pharmaceutical (OHRP) Announces Additional Squalamine Eye Drop (OHR-102) Phase 2 Clinical Data In Wet-AMD; The IMPACT Study 8/13/2014 7:28:57 AM
Ohr Pharmaceutical (OHRP) Announces Squalamine Eye Drop (OHR-102) Phase 2 Clinical Data in Retinal Vein Occlusion 8/11/2014 7:26:13 AM
Ohr Pharmaceutical (OHRP) To Present At The 2014 Wedbush Life Sciences Management Access Conference 8/8/2014 8:03:42 AM
12345678